BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank86
3Y CAGR+23.1%
5Y CAGR-22.7%
Studio
Year-over-Year Change

Return on equity

3Y CAGR
+23.1%/yr
Annual compound
5Y CAGR
-22.7%/yr
Recent acceleration
Percentile
P86
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
20255.73%-24.0%
20247.54%+122.8%
20233.39%+10.1%
20223.08%+304.7%
2021-1.50%-107.2%
202020.80%+2823.2%
2019-0.76%+70.6%
2018-2.60%+37.6%
2017-4.17%+81.7%
2016-22.78%-